T. Starr

发表

Randomised controlled trials: the long hard climb to the summit-is there another way in the 21st century?

R. Bellomo, J. Dulhunty, J. Lipman, 2014, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients

S. Parker, J. Roberts, J. Lipman, 2019, Critical Care.

Cortisol responses at baseline and after corticotropin in acute aneurysmal subarachnoid haemorrhage: a prospective study.

J. Ungerer, B. Venkatesh, T. Starr, 2015, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study

J. Rello, A. Rhodes, M. Bassetti, 2014, Critical Care.

Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center Study

G. Joynt, J. Roberts, A. Heffernan, 2022, Antimicrobial agents and chemotherapy.

Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients

M. Roberts, J. Roberts, A. Alobaid, 2017, Antimicrobial Agents and Chemotherapy.

Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients

M. Roberts, J. Roberts, A. Alobaid, 2016, Antimicrobial Agents and Chemotherapy.

Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients

M. Roberts, J. Roberts, A. Alobaid, 2016, Antimicrobial Agents and Chemotherapy.

A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.

R. Bellomo, S. Paul, D. Paterson, 2013, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study

J. Rello, A. Rhodes, M. Bassetti, 2015, Critical Care.

Glucocorticoid Sensitivity Is Highly Variable in Critically Ill Patients With Septic Shock and Is Associated With Disease Severity*

A. Blumenthal, J. Cardinal, J. Ungerer, 2016, Critical care medicine.

Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units

Juan Mauricio Pardo Oviedo, A. Nica, M. Antonelli, 2021, Drugs.

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort.

J. Rello, A. Rhodes, M. Bassetti, 2016, The Journal of antimicrobial chemotherapy.

A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.

S. Brett, A. Rhodes, D. Paterson, 2019, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction

S. Parker, J. Roberts, J. Lipman, 2019, Antimicrobial Agents and Chemotherapy.

Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.

Juan Mauricio Pardo Oviedo, A. Nica, M. Antonelli, 2022, Intensive care medicine.

Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

J. Rello, M. Bassetti, D. Koulenti, 2014, Intensive Care Medicine.

DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

J. Rello, S. Paul, A. Rhodes, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

DALI : De fi ning Antibiotic Levels in Intensive Care Unit Patients : Are Current β-Lactam Antibiotic Doses Suf fi cient for Critically Ill Patients ?

J. Rello, S. Paul, A. Rhodes, 2014 .

Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds

J. Roberts, A. Udy, J. Lipman, 2014, Critical Care.

A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltration.

J. Roberts, J. Lipman, T. Starr, 2018, International journal of antimicrobial agents.

Pharmacokinetics of Intravenous Posaconazole in Critically Ill Patients

J. Roberts, J. Lipman, T. Starr, 2018, Antimicrobial Agents and Chemotherapy.

Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project

Juan Mauricio Pardo Oviedo, A. Nica, M. Antonelli, 2019, Intensive Care Medicine.

Roberts Risk factors for target non-attainment during empirical treatment with b-lactam antibiotics in critically ill patients

J. Rello, M. Bassetti, D. Koulenti, 2014 .

Early sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial

R. Bellomo, J. Ball, N. Zabidi, 2021, Intensive Care Medicine.

Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI Study.

J. Rello, M. Bassetti, V. Stove, 2014, International journal of antimicrobial agents.

Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.

J. Roberts, A. Udy, J. Lipman, 2014, The Journal of antimicrobial chemotherapy.

A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.

R. Bellomo, S. Paul, D. Paterson, 2015, American journal of respiratory and critical care medicine.

Reply to Rhodes et al.

J. Rello, S. Paul, A. Rhodes, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic

J. Rello, A. Rhodes, J. D. De Waele, 2012, BMC Infectious Diseases.

Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance.

A. Bulmer, K. Bisht, R. Boots, 2017, Journal of neurotrauma.

Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.

R. Bellomo, S. Paul, D. Paterson, 2017, International journal of antimicrobial agents.

A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations

R. Boots, A. Udy, J. Lipman, 2013, BMC Nephrology.

Evaluation of low-volume plasma sampling for the analysis of meropenem in clinical samples

M. Chatfield, Avinash Chikatamarla, S. Parker, 2022, Analytical and Bioanalytical Chemistry.

The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: Data from the multinational SMARRT Study.

R. Bellomo, J. Rello, K. Klein, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis

M. Roberts, S. Peake, T. Robertson, 2015, Antimicrobial Agents and Chemotherapy.

Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients?

D. Paterson, J. Paratz, C. Gomersall, 2016, Journal of critical care.

Is inhaled prophylactic heparin useful for prevention and Management of Pneumonia in ventilated ICU patients?: The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group.

D. Paterson, J. Paratz, C. Gomersall, 2016, Journal of critical care.

A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration

S. Parker, J. Roberts, J. Lipman, 2019, Antimicrobial Agents and Chemotherapy.

Analysis of capillary microsamples obtained from a skin‐prick to measure vancomycin concentrations as a valid alternative to conventional sampling: A bridging study

S. Parker, J. Roberts, J. Lipman, 2019, Journal of pharmaceutical and biomedical analysis.

Ventilation practices in burn patients—an international prospective observational cohort study

P. Pelosi, K. Colpaert, J. Binnekade, 2021, Burns & trauma.

SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients

R. Bellomo, S. Paul, J. Turnidge, 2016, BMC Infectious Diseases.

Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain

S. Parker, J. Roberts, J. Lipman, 2020, Antimicrobial Agents and Chemotherapy.

Dysnatremia and 6-Month Functional Outcomes in Critically Ill Patients With Aneurysmal Subarachnoid Hemorrhage: A Prospective Cohort Study

R. Bellomo, A. Delaney, D. Cooper, 2021, Critical care explorations.

Erratum to “Is inhaled prophylactic heparin useful for prevention and management of pneumonia in ventilated ICU patients? The IPHIVAP investigators of the Australian and New Zealand Intensive Care Society Clinical Trials Group” Journal of Critical Care 34 (2016) 95–102

D. Paterson, J. Paratz, C. Gomersall, 2016 .